Ultragenyx Pharmaceutical | Aktuelle Verpflichtungen

Current Liabilities Veränderung Datum
Acadia Pharmaceuticals USD 254.25M 44.65M 2023-12
Agios Pharmaceuticals USD 67.96M 9.53M 2023-12
Alnylam Pharmaceuticals USD 967.79M 18M 2023-12
BioMarin Pharmaceutical USD 1.18B 13.8M 2023-12
Insmed USD 225.63M 28.9M 2023-12
Ionis Pharmaceuticals USD 448.09M 43.88M 2023-12
Kyowa Hakko Kirin JPY 132.61B 9.7B 2023-09
Moderna USD 3.02B 1.37B 2023-12
Neurocrine Biosciences USD 691.6M 109.1M 2023-09
PTC Therapeutics USD 603.1M 110.98M 2023-12
Regeneron Pharmaceuticals USD 4.4B 805.6M 2023-12
Sarepta Therapeutics USD 450.74M 47.91M 2023-09
Ultragenyx Pharmaceutical USD 253.98M 9.6M 2023-09
Vertex Pharmaceuticals USD 3.6B 247.3M 2023-09



Ultragenyx Pharmaceutical Aktuelle Verpflichtungen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2024.